glp 1 vs zepbound Weight-Loss Drug Now in Single-Dose Vials at Half the Price Compounded GLP-1 vs FDA-Approved Zepbound
Description
doi: 10.1186/1475-2840-10-22
&srotate=0)
Specific GLP-1 receptor agonists (liraglutide, semaglutide, dulaglutide) have demonstrated cardiovascular benefits in clinical trials, including reduced risk of major adverse cardiovascular events
However, only 0.5% of the population falls in the high-income bracket that can comfortably afford expensive GLP-1 therapies
Wang, L., Xu, R., Kaelber, D
And this was an extraordinarily important push because what it has resulted in, of course, has been spectacular
24(3): e13543
